Following CDC approval to vaccinate children ages 6 months to 5 years, 4-year-old Eleanor Kahn sits with her father, Alex, as nurse Jillian Mercer administers Moderna’s coronavirus disease (COVID-19) vaccine at Rady Children’s Hospital in San Diego . , California, USA, 21 June 2022.
Mike Blake | Reuters
Modern has asked the Food and Drug Administration for approval of its Omicron booster vaccines for children, the company said Friday.
Moderna filed two separate applications for FDA approval, one for adolescents ages 12 to 17 and another for children ages 6 to 11. The Boston-based biotech company said it will also apply to the FDA to approve vaccines for the youngest children, ages 6 months to 5 years. -old, later this year.
The Centers for Disease Control and Prevention said in a document released Tuesday that it expects children to become eligible for Omicron boosters by mid-October, pending FDA approval. CDC’s Vaccine Advisory Committee has meetings scheduled for October 19 and 20.
Pfizer told a CDC advisory committee earlier this month that he expects the FDA to apply for approval of micron pacemakers for children ages 5 to 11 in early October.
US health regulators eliminated Moderna’s micron boosters for adults earlier this month. Pfizer’s stimulants have been approved for people 12 years of age and older.
The new vaccines target the omicron BA.5 sub-variant as well as the original strain of Covid that first appeared in China in late 2019. The FDA and CDC expect the new boosters to provide superior protection against infection and disease because they target the most common omicron sub-variant .
The old vaccines that were designed to fight the original strain of Covid no longer provide meaningful protection against infection and mild illness because the virus has mutated so much. There is also concern that the effectiveness of the original vaccinations in preventing hospitalization and serious illness is waning.
Public health officials are confident about the new BA.5 micron boosters, although it’s unclear how effective they will be in the real world. Vaccines were licensed without data from human clinical trials